{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:11:30Z","timestamp":1788383490330,"version":"build-2803163510"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncol Ther"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s40487-024-00300-8","type":"journal-article","created":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T13:01:51Z","timestamp":1725195711000},"page":"663-683","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Causal Relationship Between Gut Microbiota and Leukemia: Future Perspectives"],"prefix":"10.1007","volume":"12","author":[{"given":"Qiang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2065-0793","authenticated-orcid":false,"given":"Zexin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,1]]},"reference":[{"issue":"103","key":"300_CR1","first-page":"38","volume":"2020","author":"A Pelcovits","year":"2013","unstructured":"Pelcovits A, Niroula R. Acute myeloid leukemia: a review. R I Med J. 2013;2020(103):38\u201340.","journal-title":"R I Med J"},{"key":"300_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1159\/000447076","volume":"43","author":"G Juliusson","year":"2016","unstructured":"Juliusson G, Hough R. Leukemia. Prog Tumor Res. 2016;43:87\u2013100.","journal-title":"Prog Tumor Res"},{"key":"300_CR3","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a034819","volume":"10","author":"JAB Bispo","year":"2020","unstructured":"Bispo JAB, Pinheiro PS, Kobetz EK. Epidemiology and etiology of leukemia and lymphoma. Cold Spring Harb Perspect Med. 2020;10: a034819.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"300_CR4","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020 GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021. https:\/\/doi.org\/10.3322\/caac.21660.","journal-title":"CA Cancer J Clin"},{"key":"300_CR5","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","volume":"18","author":"E Steliarova-Foucher","year":"2017","unstructured":"Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, et al. International incidence of childhood cancer, 2001\u201310: a population-based registry study. Lancet Oncol. 2017;18:719\u201331.","journal-title":"Lancet Oncol"},{"key":"300_CR6","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a035220","volume":"11","author":"N Chiorazzi","year":"2021","unstructured":"Chiorazzi N, Chen S-S, Rai KR. Chronic lymphocytic leukemia. Cold Spring Harb Perspect Med. 2021;11: a035220.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"300_CR7","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3960\/jslrt.20036","volume":"60","author":"Y Kikushige","year":"2020","unstructured":"Kikushige Y. Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategies. J Clin Exp Hematop JCEH. 2020;60:146\u201358.","journal-title":"J Clin Exp Hematop JCEH"},{"key":"300_CR8","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/ajh.26642","volume":"97","author":"E Jabbour","year":"2022","unstructured":"Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring. Am J Hematol. 2022;97:1236\u201356.","journal-title":"Am J Hematol"},{"key":"300_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.6004\/jnccn.2024.0007","volume":"22","author":"NP Shah","year":"2024","unstructured":"Shah NP, Bhatia R, Altman JK, Amaya M, Begna KH, Berman E, et al. Chronic myeloid leukemia, version 2. 2024, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw JNCCN. 2024;22:43\u201369.","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"key":"300_CR10","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","volume":"140","author":"DA Arber","year":"2022","unstructured":"Arber DA, Orazi A, Hasserjian RP, Borowitz MJ, Calvo KR, Kvasnicka H-M, et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022;140:1200\u201328.","journal-title":"Blood"},{"key":"300_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nature25973","volume":"555","author":"D Rothschild","year":"2018","unstructured":"Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555:210\u20135.","journal-title":"Nature"},{"key":"300_CR12","doi-asserted-by":"publisher","first-page":"e00036","DOI":"10.1128\/MMBR.00036-17","volume":"81","author":"C Milani","year":"2017","unstructured":"Milani C, Duranti S, Bottacini F, Casey E, Turroni F, Mahony J, et al. The first microbial colonizers of the human gut: composition, activities, and health implications of the infant gut microbiota. Microbiol Mol Biol Rev MMBR. 2017;81:e00036-e117.","journal-title":"Microbiol Mol Biol Rev MMBR"},{"key":"300_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3389\/fimmu.2014.00427","volume":"5","author":"M-C Arrieta","year":"2014","unstructured":"Arrieta M-C, Stiemsma LT, Amenyogbe N, Brown EM, Finlay B. The intestinal microbiome in early life: health and disease. Front Immunol. 2014;5:427.","journal-title":"Front Immunol"},{"key":"300_CR14","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/ismej.2015.177","volume":"10","author":"J Cheng","year":"2016","unstructured":"Cheng J, Ringel-Kulka T, Heikamp-de Jong I, Ringel Y, Carroll I, de Vos WM, et al. Discordant temporal development of bacterial phyla and the emergence of core in the fecal microbiota of young children. ISME J. 2016;10:1002\u201314.","journal-title":"ISME J"},{"key":"300_CR15","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40168-015-0101-x","volume":"3","author":"EB Hollister","year":"2015","unstructured":"Hollister EB, Riehle K, Luna RA, Weidler EM, Rubio-Gonzales M, Mistretta T-A, et al. Structure and function of the healthy pre-adolescent pediatric gut microbiome. Microbiome. 2015;3:36.","journal-title":"Microbiome"},{"key":"300_CR16","doi-asserted-by":"publisher","first-page":"1045497","DOI":"10.3389\/fmicb.2022.1045497","volume":"13","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Zhou C, Zhang A. Gut microbiota in acute leukemia: current evidence and future directions. Front Microbiol. 2022;13:1045497.","journal-title":"Front Microbiol"},{"key":"300_CR17","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1152\/physrev.00045.2009","volume":"90","author":"I Sekirov","year":"2010","unstructured":"Sekirov I, Russell SL, Antunes LCM, Finlay BB. Gut microbiota in health and disease. Physiol Rev. 2010;90:859\u2013904.","journal-title":"Physiol Rev"},{"key":"300_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/MOG.0000000000000139","volume":"31","author":"AB Shreiner","year":"2015","unstructured":"Shreiner AB, Kao JY, Young VB. The gut microbiome in health and in disease. Curr Opin Gastroenterol. 2015;31:69\u201375.","journal-title":"Curr Opin Gastroenterol"},{"key":"300_CR19","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/jgs.13310","volume":"63","author":"HJ Zapata","year":"2015","unstructured":"Zapata HJ, Quagliarello VJ. The microbiota and microbiome in aging: potential implications in health and age-related diseases. J Am Geriatr Soc. 2015;63:776\u201381.","journal-title":"J Am Geriatr Soc"},{"key":"300_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0283-6","volume":"51","author":"Y Maeda","year":"2019","unstructured":"Maeda Y, Takeda K. Host-microbiota interactions in rheumatoid arthritis. Exp Mol Med. 2019;51:1\u20136.","journal-title":"Exp Mol Med"},{"key":"300_CR21","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2174\/18756190MTA3fMTUq5","volume":"19","author":"G Kaur","year":"2021","unstructured":"Kaur G, Behl T, Bungau S, Kumar A, Uddin MS, Mehta V, et al. Dysregulation of the gut-brain axis, dysbiosis and influence of numerous factors on gut microbiota associated Parkinson\u2019s disease. Curr Neuropharmacol. 2021;19:233\u201347.","journal-title":"Curr Neuropharmacol"},{"key":"300_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nrgastro.2017.72","volume":"14","author":"L-X Yu","year":"2017","unstructured":"Yu L-X, Schwabe RF. The gut microbiome and liver cancer: mechanisms and clinical translation. Nat Rev Gastroenterol Hepatol. 2017;14:527\u201339.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"300_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2020.01.007","volume":"52","author":"W Barcik","year":"2020","unstructured":"Barcik W, Boutin RCT, Sokolowska M, Finlay BB. The role of lung and gut microbiota in the pathology of asthma. Immunity. 2020;52:241\u201355.","journal-title":"Immunity"},{"key":"300_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nature08821","volume":"464","author":"J Qin","year":"2010","unstructured":"Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59\u201365.","journal-title":"Nature"},{"key":"300_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.gpb.2015.02.005","volume":"13","author":"RS Mandal","year":"2015","unstructured":"Mandal RS, Saha S, Das S. Metagenomic surveys of gut microbiota. Genom Proteom Bioinform. 2015;13:148\u201358.","journal-title":"Genom Proteom Bioinform"},{"key":"300_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1003107","volume":"9","author":"DR Riley","year":"2013","unstructured":"Riley DR, Sieber KB, Robinson KM, White JR, Ganesan A, Nourbakhsh S, et al. Bacteria-human somatic cell lateral gene transfer is enriched in cancer samples. PLoS Comput Biol. 2013;9: e1003107.","journal-title":"PLoS Comput Biol"},{"key":"300_CR27","first-page":"67","volume":"77","author":"A Allegra","year":"2019","unstructured":"Allegra A, Innao V, Allegra AG, Ettari R, Pugliese M, Pulvirenti N, et al. Role of the microbiota in hematologic malignancies. Neth J Med. 2019;77:67\u201380.","journal-title":"Neth J Med"},{"key":"300_CR28","doi-asserted-by":"publisher","first-page":"1185787","DOI":"10.3389\/fmicb.2023.1185787","volume":"14","author":"P Guevara-Ram\u00edrez","year":"2023","unstructured":"Guevara-Ram\u00edrez P, Cadena-Ullauri S, Paz-Cruz E, Tamayo-Trujillo R, Ruiz-Pozo VA, Zambrano AK. Role of the gut microbiota in hematologic cancer. Front Microbiol. 2023;14:1185787.","journal-title":"Front Microbiol"},{"key":"300_CR29","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","volume":"71","author":"WM de Vos","year":"2022","unstructured":"de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71:1020\u201332.","journal-title":"Gut"},{"key":"300_CR30","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12934-020-01477-z","volume":"20","author":"A Nakkarach","year":"2021","unstructured":"Nakkarach A, Foo HL, Song AA-L, Mutalib NEA, Nitisinprasert S, Withayagiat U. Anti-cancer and anti-inflammatory effects elicited by short chain fatty acids produced by Escherichia coli isolated from healthy human gut microbiota. Microb Cell Fact. 2021;20:36.","journal-title":"Microb Cell Fact"},{"key":"300_CR31","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1136\/gutjnl-2020-321153","volume":"69","author":"WY Cheng","year":"2020","unstructured":"Cheng WY, Wu C-Y, Yu J. The role of gut microbiota in cancer treatment: friend or foe? Gut. 2020;69:1867\u201376.","journal-title":"Gut"},{"key":"300_CR32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/08880018.2020.1759740","volume":"37","author":"R Thomas","year":"2020","unstructured":"Thomas R, Wong WSW, Saadon R, Vilboux T, Deeken J, Niederhuber J, et al. Gut microbial composition difference between pediatric ALL survivors and siblings. Pediatr Hematol Oncol. 2020;37:475\u201388.","journal-title":"Pediatr Hematol Oncol"},{"key":"300_CR33","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/ijc.32942","volume":"147","author":"S De Pietri","year":"2020","unstructured":"De Pietri S, Ingham AC, Frandsen TL, Rathe M, Krych L, Castro-Mej\u00eda JL, et al. Gastrointestinal toxicity during induction treatment for childhood acute lymphoblastic leukemia: The impact of the gut microbiota. Int J Cancer. 2020;147:1953\u201362.","journal-title":"Int J Cancer"},{"key":"300_CR34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/08880018.2020.1793850","volume":"37","author":"LM Sly","year":"2020","unstructured":"Sly LM. Gut microbes in pediatric ALL survivorship. Pediatr Hematol Oncol. 2020;37:451\u20134.","journal-title":"Pediatr Hematol Oncol"},{"key":"300_CR35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1093\/cid\/ciy153","volume":"67","author":"H Hakim","year":"2018","unstructured":"Hakim H, Dallas R, Wolf J, Tang L, Schultz-Cherry S, Darling V, et al. Gut microbiome composition predicts infection risk during chemotherapy in children with acute lymphoblastic leukemia. Clin Infect Dis Off Publ Infect Dis Soc Am. 2018;67:541\u20138.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"300_CR36","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1182\/blood.2019004381","volume":"136","author":"C Vicente-Due\u00f1as","year":"2020","unstructured":"Vicente-Due\u00f1as C, Janssen S, Oldenburg M, Auer F, Gonz\u00e1lez-Herrero I, Casado-Garc\u00eda A, et al. An intact gut microbiome protects genetically predisposed mice against leukemia. Blood. 2020;136:2003\u201317.","journal-title":"Blood"},{"key":"300_CR37","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1158\/1055-9965.EPI-17-0778","volume":"27","author":"EL Marcotte","year":"2018","unstructured":"Marcotte EL, Richardson MR, Roesler MA, Spector LG. Cesarean delivery and risk of infant leukemia: a report from the Children\u2019s Oncology Group. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol. 2018;27:473\u20138.","journal-title":"Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol"},{"key":"300_CR38","doi-asserted-by":"publisher","first-page":"4619","DOI":"10.1182\/bloodadvances.2021005129","volume":"5","author":"R Masetti","year":"2021","unstructured":"Masetti R, Muratore E, Leardini D, Zama D, Turroni S, Brigidi P, et al. Gut microbiome in pediatric acute leukemia: from predisposition to cure. Blood Adv. 2021;5:4619\u201329.","journal-title":"Blood Adv"},{"key":"300_CR39","doi-asserted-by":"publisher","first-page":"5724","DOI":"10.3390\/ijms20225724","volume":"20","author":"H Li","year":"2019","unstructured":"Li H, Sun B, Ning X, Jiang S, Sun L. A comparative analysis of Edwardsiella tarda-induced transcriptome profiles in RAW264.7 cells reveals new insights into the strategy of bacterial immune evasion. Int J Mol Sci. 2019;20:5724.","journal-title":"Int J Mol Sci."},{"key":"300_CR40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","volume":"14","author":"AD Kostic","year":"2013","unstructured":"Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013;14:207\u201315.","journal-title":"Cell Host Microbe"},{"key":"300_CR41","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.cell.2016.11.046","volume":"167","author":"M Schirmer","year":"2016","unstructured":"Schirmer M, Smeekens SP, Vlamakis H, Jaeger M, Oosting M, Franzosa EA, et al. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell. 2016;167:1897.","journal-title":"Cell"},{"key":"300_CR42","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.3324\/haematol.2021.280455","volume":"107","author":"T Faitov\u00e1","year":"2022","unstructured":"Faitov\u00e1 T, Svanberg R, Da Cunha-Bang C, Ilett EE, J\u00f8rgensen M, Noguera-Julian M, et al. The gut microbiome in patients with chronic lymphocytic leukemia. Haematologica. 2022;107:2238\u201343.","journal-title":"Haematologica"},{"key":"300_CR43","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1182\/blood-2019-121643","volume":"134","author":"M Kawari","year":"2019","unstructured":"Kawari M, Akhtar M, Sager M, Basbous Z, Baydoun I, Kabanja J, et al. Alterations of gut microbiome in untreated chronic lymphocytic leukemia (CLL) future therapeutic potentials. Blood. 2019;134:5455. https:\/\/doi.org\/10.1182\/blood-2019-121643.","journal-title":"Blood"},{"key":"300_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/cid\/ciz777","volume":"71","author":"JR Galloway-Pe\u00f1a","year":"2020","unstructured":"Galloway-Pe\u00f1a JR, Shi Y, Peterson CB, Sahasrabhojane P, Gopalakrishnan V, Brumlow CE, et al. Gut microbiome signatures are predictive of infectious risk following induction therapy for acute myeloid leukemia. Clin Infect Dis. 2020;71:63\u201371.","journal-title":"Clin Infect Dis"},{"key":"300_CR45","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/cncr.30039","volume":"122","author":"JR Galloway-Pe\u00f1a","year":"2016","unstructured":"Galloway-Pe\u00f1a JR, Smith DP, Sahasrabhojane P, Ajami NJ, Wadsworth WD, Daver NG, et al. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia. Cancer. 2016;122:2186\u201396.","journal-title":"Cancer"},{"key":"300_CR46","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1182\/bloodadvances.2021006783","volume":"6","author":"A Rashidi","year":"2022","unstructured":"Rashidi A, Ebadi M, Rehman TU, Elhusseini H, Halaweish HF, Kaiser T, et al. Lasting shift in the gut microbiota in patients with acute myeloid leukemia. Blood Adv. 2022;6:3451\u20137.","journal-title":"Blood Adv"},{"key":"300_CR47","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/j.clnu.2023.09.021","volume":"42","author":"SA P\u00f6tgens","year":"2023","unstructured":"P\u00f6tgens SA, Lecop S, Havelange V, Li F, Neyrinck AM, Neveux N, et al. Gut microbiota alterations induced by intensive chemotherapy in acute myeloid leukaemia patients are associated with gut barrier dysfunction and body weight loss. Clin Nutr. 2023;42:2214\u201328.","journal-title":"Clin Nutr"},{"key":"300_CR48","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/2211-5463.13193","volume":"11","author":"D Yu","year":"2021","unstructured":"Yu D, Yu X, Ye A, Xu C, Li X, Geng W, et al. Profiling of gut microbial dysbiosis in adults with myeloid leukemia. FEBS Open Bio. 2021;11:2050\u20139.","journal-title":"FEBS Open Bio"},{"key":"300_CR49","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/1574-6941.12127","volume":"85","author":"B van den Bogert","year":"2013","unstructured":"van den Bogert B, Erkus O, Boekhorst J, de Goffau M, Smid EJ, Zoetendal EG, et al. Diversity of human small intestinal Streptococcus and Veillonella populations. FEMS Microbiol Ecol. 2013;85:376\u201388.","journal-title":"FEMS Microbiol Ecol"},{"key":"300_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.692951","author":"T Ma","year":"2021","unstructured":"Ma T, Chen Y, Li L-J, Zhang L-S. Opportunities and challenges for gut microbiota in acute leukemia. Front Oncol. 2021. https:\/\/doi.org\/10.3389\/fonc.2021.692951.","journal-title":"Front Oncol"},{"key":"300_CR51","first-page":"235","volume":"10","author":"MS Almuhayawi","year":"2021","unstructured":"Almuhayawi MS, Mohamed MSM, Abdel-Mawgoud M, Selim S, Al Jaouni SK, AbdElgawad H. Bioactive potential of several actinobacteria isolated from microbiologically barely explored desert habitat. Saudi Arab Biol. 2021;10:235.","journal-title":"Saudi Arab Biol"},{"key":"300_CR52","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3390\/nu15010048","volume":"15","author":"Z Li","year":"2022","unstructured":"Li Z, Ke X, Zuo D, Wang Z, Fang F, Li B. New insights into the relationship between gut microbiota and radiotherapy for cancer. Nutrients. 2022;15:48.","journal-title":"Nutrients"},{"key":"300_CR53","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12916-023-02761-6","volume":"21","author":"Y Long","year":"2023","unstructured":"Long Y, Tang L, Zhou Y, Zhao S, Zhu H. Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study. BMC Med. 2023;21:66.","journal-title":"BMC Med"},{"key":"300_CR54","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13046-021-01983-x","volume":"40","author":"X Liu","year":"2021","unstructured":"Liu X, Chen Y, Zhang S, Dong L. Gut microbiota-mediated immunomodulation in tumor. J Exp Clin Cancer Res CR. 2021;40:221.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"300_CR55","volume":"10","author":"R Qu","year":"2023","unstructured":"Qu R, Zhang Y, Ma Y, Zhou X, Sun L, Jiang C, et al. Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer. Adv Sci Weinh Baden-Wurtt Ger. 2023;10: e2205563.","journal-title":"Adv Sci Weinh Baden-Wurtt Ger"},{"key":"300_CR56","doi-asserted-by":"publisher","first-page":"2236364","DOI":"10.1080\/19490976.2023.2236364","volume":"15","author":"Z Wang","year":"2023","unstructured":"Wang Z, Dan W, Zhang N, Fang J, Yang Y. Colorectal cancer and gut microbiota studies in China. Gut Microbes. 2023;15:2236364.","journal-title":"Gut Microbes"},{"key":"300_CR57","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1007\/s00432-021-03644-0","volume":"147","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Liu Y, Li S, Peng Z, Liu X, Chen J, et al. Role of lung and gut microbiota on lung cancer pathogenesis. J Cancer Res Clin Oncol. 2021;147:2177\u201386.","journal-title":"J Cancer Res Clin Oncol"},{"key":"300_CR58","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3390\/toxins10070287","volume":"10","author":"MT Velasquez","year":"2018","unstructured":"Velasquez MT, Centron P, Barrows I, Dwivedi R, Raj DS. Gut microbiota and cardiovascular uremic toxicities. Toxins. 2018;10:287.","journal-title":"Toxins"},{"key":"300_CR59","doi-asserted-by":"publisher","first-page":"1321395","DOI":"10.3389\/fimmu.2024.1321395","volume":"15","author":"A Luqman","year":"2024","unstructured":"Luqman A, Hassan A, Ullah M, Naseem S, Ullah M, Zhang L, et al. Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder. Front Immunol. 2024;15:1321395.","journal-title":"Front Immunol"},{"key":"300_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121947","volume":"329","author":"M Hemmati","year":"2023","unstructured":"Hemmati M, Kashanipoor S, Mazaheri P, Alibabaei F, Babaeizad A, Asli S, et al. Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD). Life Sci. 2023;329: 121947.","journal-title":"Life Sci"},{"key":"300_CR61","doi-asserted-by":"publisher","first-page":"5110276","DOI":"10.1155\/2021\/5110276","volume":"2021","author":"L Zhang","year":"2021","unstructured":"Zhang L, Chu J, Hao W, Zhang J, Li H, Yang C, et al. Gut microbiota and type 2 diabetes mellitus: association, mechanism, and translational applications. Mediat Inflamm. 2021;2021:5110276.","journal-title":"Mediat Inflamm"},{"key":"300_CR62","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/HPC.0000000000000187","volume":"18","author":"V Mantziaris","year":"2019","unstructured":"Mantziaris V, Kolios G. Gut microbiota, atherosclerosis, and therapeutic targets. Crit Pathw Cardiol. 2019;18:139\u201342.","journal-title":"Crit Pathw Cardiol"},{"key":"300_CR63","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature18846","volume":"535","author":"JL Sonnenburg","year":"2016","unstructured":"Sonnenburg JL, B\u00e4ckhed F. Diet-microbiota interactions as moderators of human metabolism. Nature. 2016;535:56\u201364.","journal-title":"Nature"},{"key":"300_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1540","volume":"14","author":"L Chen","year":"2022","unstructured":"Chen L, Wang J. Gut microbiota and inflammatory bowel disease. WIREs Mech Dis. 2022;14: e1540.","journal-title":"WIREs Mech Dis"},{"issue":"45","key":"300_CR65","first-page":"2195135","volume":"2023","author":"Z Yang","year":"1993","unstructured":"Yang Z, Wang Q, Liu Y, Wang L, Ge Z, Li Z, et al. Gut microbiota and hypertension: association, mechanisms and treatment. Clin Exp Hypertens N Y N. 1993;2023(45):2195135.","journal-title":"Clin Exp Hypertens N Y N"},{"key":"300_CR66","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s11154-019-09512-0","volume":"20","author":"M Schoeler","year":"2019","unstructured":"Schoeler M, Caesar R. Dietary lipids, gut microbiota and lipid metabolism. Rev Endocr Metab Disord. 2019;20:461\u201372.","journal-title":"Rev Endocr Metab Disord"},{"key":"300_CR67","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1128\/AEM.66.4.1654-1661.2000","volume":"66","author":"A Barcenilla","year":"2000","unstructured":"Barcenilla A, Pryde SE, Martin JC, Duncan SH, Stewart CS, Henderson C, et al. Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol. 2000;66:1654\u201361.","journal-title":"Appl Environ Microbiol"},{"key":"300_CR68","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3390\/ijms23031105","volume":"23","author":"P Portincasa","year":"2022","unstructured":"Portincasa P, Bonfrate L, Vacca M, De Angelis M, Farella I, Lanza E, et al. Gut microbiota and short chain fatty acids: implications in glucose homeostasis. Int J Mol Sci. 2022;23:1105.","journal-title":"Int J Mol Sci"},{"key":"300_CR69","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.tem.2020.12.003","volume":"32","author":"L Zhang","year":"2021","unstructured":"Zhang L, Liu C, Jiang Q, Yin Y. Butyrate in energy metabolism: there is still more to learn. Trends Endocrinol Metab. 2021;32:159\u201369.","journal-title":"Trends Endocrinol Metab"},{"key":"300_CR70","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1038\/s41467-022-30240-8","volume":"13","author":"R Wang","year":"2022","unstructured":"Wang R, Yang X, Liu J, Zhong F, Zhang C, Chen Y, et al. Gut microbiota regulates acute myeloid leukaemia via alteration of intestinal barrier function mediated by butyrate. Nat Commun. 2022;13:2522.","journal-title":"Nat Commun"},{"key":"300_CR71","first-page":"1019034","volume":"2018","author":"M Ghrewati","year":"2018","unstructured":"Ghrewati M, Manji F, Modi V, Chandran C, Maroules M. Severe metabolic acidemia in a patient with aleukemic leukemia. Case Rep Nephrol. 2018;2018:1019034.","journal-title":"Case Rep Nephrol"},{"key":"300_CR72","first-page":"61","volume":"54","author":"M G\u00f6k\u00e7e","year":"2012","unstructured":"G\u00f6k\u00e7e M, Unal S, G\u00fcl\u015fen H, Ba\u015faran O, Cetin M, G\u00fcmr\u00fck F, et al. A rare metabolic complication of acute lymphoblastic leukemia in childhood: lactic acidosis. Turk J Pediatr. 2012;54:61\u20133.","journal-title":"Turk J Pediatr"},{"key":"300_CR73","doi-asserted-by":"publisher","first-page":"453","DOI":"10.12659\/AJCR.907383","volume":"19","author":"AH Sayyed","year":"2018","unstructured":"Sayyed AH, Aleem A, Al-Katari MS, Algahtani F, Aljerian K, Aleem TA, et al. Acute lymphoblastic leukemia presenting with liver infiltration and severe lactic acidosis. Am J Case Rep. 2018;19:453\u20137.","journal-title":"Am J Case Rep"},{"key":"300_CR74","volume":"13","author":"J Padda","year":"2021","unstructured":"Padda J, Khalid K, Kakani V, Cooper AC, Jean-Charles G. Metabolic acidosis in leukemia. Cureus. 2021;13: e17732.","journal-title":"Cureus"},{"key":"300_CR75","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s12029-019-00329-3","volume":"51","author":"M Eslami","year":"2020","unstructured":"Eslami M, Sadrifar S, Karbalaei M, Keikha M, Kobyliak NM, Yousefi B. Importance of the microbiota inhibitory mechanism on the Warburg effect in colorectal cancer cells. J Gastrointest Cancer. 2020;51:738\u201347.","journal-title":"J Gastrointest Cancer"},{"key":"300_CR76","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cmet.2020.03.001","volume":"31","author":"K Lund\u00f8","year":"2020","unstructured":"Lund\u00f8 K, Trauelsen M, Pedersen SF, Schwartz TW. Why Warburg works: lactate controls immune evasion through GPR81. Cell Metab. 2020;31:666\u20138.","journal-title":"Cell Metab"},{"key":"300_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107451","volume":"206","author":"TP Brown","year":"2020","unstructured":"Brown TP, Ganapathy V. Lactate\/GPR81 signaling and proton motive force in cancer: role in angiogenesis, immune escape, nutrition, and Warburg phenomenon. Pharmacol Ther. 2020;206: 107451.","journal-title":"Pharmacol Ther"},{"key":"300_CR78","first-page":"1523","volume":"10","author":"KL Noonan","year":"2015","unstructured":"Noonan KL, Ho C, Laskin J, Murray N. The influence of the evolution of first-line chemotherapy on steadily improving survival in advanced non-small-cell lung cancer clinical trials. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2015;10:1523\u201331.","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"key":"300_CR79","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/cts.12722","volume":"13","author":"M Lucaf\u00f2","year":"2020","unstructured":"Lucaf\u00f2 M, Franzin M, Lagatolla C, Franca R, Bramuzzo M, Stocco G, et al. Emerging insights on the interaction between anticancer and immunosuppressant drugs and intestinal microbiota in pediatric patients. Clin Transl Sci. 2020;13:238\u201359.","journal-title":"Clin Transl Sci"},{"key":"300_CR80","doi-asserted-by":"publisher","first-page":"e45221","DOI":"10.1371\/journal.pone.0045221","volume":"7","author":"S Ben-Lulu","year":"2012","unstructured":"Ben-Lulu S, Pollak Y, Mogilner J, Bejar J, Coran GA, Sukhotnik I. Dietary transforming growth factor-beta 2 (TGF-\u03b22) supplementation reduces methotrexate-induced intestinal mucosal injury in a rat. PloS One. 2012;7:e45221.","journal-title":"PloS One"},{"key":"300_CR81","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s10620-012-2437-4","volume":"58","author":"VK Kolli","year":"2013","unstructured":"Kolli VK, Abraham P, Isaac B, Kasthuri N. Preclinical efficacy of melatonin to reduce methotrexate-induced oxidative stress and small intestinal damage in rats. Dig Dis Sci. 2013;58:959\u201369.","journal-title":"Dig Dis Sci"},{"key":"300_CR82","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ebiom.2018.06.029","volume":"33","author":"B Zhou","year":"2018","unstructured":"Zhou B, Xia X, Wang P, Chen S, Yu C, Huang R, et al. Induction and amelioration of methotrexate-induced gastrointestinal toxicity are related to immune response and gut microbiota. EBioMedicine. 2018;33:122\u201333.","journal-title":"EBioMedicine"},{"key":"300_CR83","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1126\/science.1240537","volume":"342","author":"S Viaud","year":"2013","unstructured":"Viaud S, Saccheri F, Mignot G, Yamazaki T, Daill\u00e8re R, Hannani D, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science. 2013;342:971\u20136.","journal-title":"Science"},{"key":"300_CR84","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1200\/JCO.21.02678","volume":"40","author":"DT Teachey","year":"2022","unstructured":"Teachey DT, Devidas M, Wood BL, Chen Z, Hayashi RJ, Hermiston ML, et al. Children\u2019s Oncology Group trial AALL1231: a phase III clinical trial testing bortezomib in newly diagnosed T-cell acute lymphoblastic leukemia and lymphoma. J Clin Oncol. 2022;40:2106\u201318.","journal-title":"J Clin Oncol."},{"key":"300_CR85","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cmet.2023.11.019","volume":"36","author":"Y Zhu","year":"2024","unstructured":"Zhu Y, Jian X, Chen S, An G, Jiang D, Yang Q, et al. Targeting gut microbial nitrogen recycling and cellular uptake of ammonium to improve bortezomib resistance in multiple myeloma. Cell Metab. 2024;36:159-175.e8.","journal-title":"Cell Metab"},{"key":"300_CR86","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.3390\/jcm12113647","volume":"12","author":"M Molica","year":"2023","unstructured":"Molica M, Perrone S, Rossi M. Gilteritinib: the story of a proceeding success into hard-to-treat FLT3-mutated AML patients. J Clin Med. 2023;12:3647.","journal-title":"J Clin Med"},{"key":"300_CR87","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jinf.2013.12.006","volume":"68","author":"M Mikulska","year":"2014","unstructured":"Mikulska M, Viscoli C, Orasch C, Livermore DM, Averbuch D, Cordonnier C, et al. Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients. J Infect. 2014;68:321\u201331.","journal-title":"J Infect"},{"key":"300_CR88","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/ajh.24489","volume":"91","author":"EM Trecarichi","year":"2016","unstructured":"Trecarichi EM, Pagano L, Martino B, Candoni A, Di Blasi R, Nadali G, et al. Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey. Am J Hematol. 2016;91:1076\u201381.","journal-title":"Am J Hematol"},{"key":"300_CR89","first-page":"55","volume":"32","author":"F Escrihuela-Vidal","year":"2019","unstructured":"Escrihuela-Vidal F, Laporte J, Albasanz-Puig A, Gudiol C. Update on the management of febrile neutropenia in hematologic patients. Rev Esp Quimioter. 2019;32:55\u20138.","journal-title":"Rev Esp Quimioter"},{"key":"300_CR90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236460","volume":"15","author":"T Rattanathammethee","year":"2020","unstructured":"Rattanathammethee T, Tuitemwong P, Thiennimitr P, Sarichai P, Na Pombejra S, Piriyakhuntorn P, et al. Gut microbiota profiles of treatment-na\u00efve adult acute myeloid leukemia patients with neutropenic fever during intensive chemotherapy. PLoS ONE. 2020;15: e0236460.","journal-title":"PLoS ONE"},{"key":"300_CR91","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s40168-021-01170-2","volume":"9","author":"A Rashidi","year":"2021","unstructured":"Rashidi A, Ebadi M, Rehman TU, Elhusseini H, Nalluri H, Kaiser T, et al. Gut microbiota response to antibiotics is personalized and depends on baseline microbiota. Microbiome. 2021;9:211.","journal-title":"Microbiome"},{"key":"300_CR92","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.3324\/haematol.2013.091769","volume":"98","author":"IC Gyssens","year":"2013","unstructured":"Gyssens IC, Kern WV, Livermore DM. The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients. Haematologica. 2013;98:1821\u20135.","journal-title":"Haematologica"},{"key":"300_CR93","first-page":"263","volume":"24","author":"Z Shen","year":"2021","unstructured":"Shen Z, Gu X, Cao H, Mao W, Yang L, He M, et al. Characterization of microbiota in acute leukemia patients following successful remission induction chemotherapy without antimicrobial prophylaxis. Int Microbiol Off J Span Soc Microbiol. 2021;24:263\u201373.","journal-title":"Int Microbiol Off J Span Soc Microbiol"},{"key":"300_CR94","doi-asserted-by":"publisher","first-page":"6083","DOI":"10.1038\/s41598-019-42652-6","volume":"9","author":"A Rashidi","year":"2019","unstructured":"Rashidi A, Kaiser T, Shields-Cutler R, Graiziger C, Holtan SG, Rehman TU, et al. Dysbiosis patterns during re-induction\/salvage versus induction chemotherapy for acute leukemia. Sci Rep. 2019;9:6083.","journal-title":"Sci Rep"},{"key":"300_CR95","doi-asserted-by":"publisher","first-page":"e94","DOI":"10.1097\/INF.0b013e3182793610","volume":"32","author":"K Laoprasopwattana","year":"2013","unstructured":"Laoprasopwattana K, Khwanna T, Suwankeeree P, Sujjanunt T, Tunyapanit W, Chelae S. Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy. Pediatr Infect Dis J. 2013;32:e94-98.","journal-title":"Pediatr Infect Dis J"},{"key":"300_CR96","first-page":"550","volume":"24","author":"S-M Chen","year":"2022","unstructured":"Chen S-M, Liu S-X, Chen F, Wang C-Y, Mai H-R, Yuan X-L, et al. Changes of intestinal flora in children with acute lymphoblastic leukemia before and after chemotherapy. Zhongguo Dang Dai Er Ke Za Zhi Chin J Contemp Pediatr. 2022;24:550\u201360.","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi Chin J Contemp Pediatr"},{"key":"300_CR97","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1186\/s12885-021-08917-y","volume":"21","author":"X Liu","year":"2021","unstructured":"Liu X, Zou Y, Zhang Y, Liu L, Duan Y, Zhang A, et al. Characteristics in gut microbiome is associated with chemotherapy-induced pneumonia in pediatric acute lymphoblastic leukemia. BMC Cancer. 2021;21:1190.","journal-title":"BMC Cancer"},{"key":"300_CR98","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214526","volume":"14","author":"Y Song","year":"2019","unstructured":"Song Y, Gyarmati P. Bacterial translocation in acute lymphocytic leukemia. PLoS ONE. 2019;14: e0214526.","journal-title":"PLoS ONE"},{"key":"300_CR99","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00280-021-04385-0","volume":"89","author":"J Liu","year":"2022","unstructured":"Liu J, Luo W, Chen Q, Chen X, Zhou G, Sun H. Curcumin sensitizes response to cytarabine in acute myeloid leukemia by regulating intestinal microbiota. Cancer Chemother Pharmacol. 2022;89:243\u201353.","journal-title":"Cancer Chemother Pharmacol"},{"key":"300_CR100","doi-asserted-by":"publisher","first-page":"5950","DOI":"10.3748\/wjg.v22.i26.5950","volume":"22","author":"E Resino","year":"2016","unstructured":"Resino E, San-Juan R, Aguado JM. Selective intestinal decontamination for the prevention of early bacterial infections after liver transplantation. World J Gastroenterol. 2016;22:5950\u20137.","journal-title":"World J Gastroenterol"},{"key":"300_CR101","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/00007890-198803000-00014","volume":"45","author":"RH Wiesner","year":"1988","unstructured":"Wiesner RH, Hermans PE, Rakela J, Washington JA, Perkins JD, DiCecco S, et al. Selective bowel decontamination to decrease gram-negative aerobic bacterial and Candida colonization and prevent infection after orthotopic liver transplantation. Transplantation. 1988;45:570\u20134.","journal-title":"Transplantation"},{"key":"300_CR102","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.diagmicrobio.2014.06.006","volume":"80","author":"MP Kronman","year":"2014","unstructured":"Kronman MP, Zerr DM, Qin X, Englund J, Cornell C, Sanders JE, et al. Intestinal decontamination of multidrug-resistant Klebsiella pneumoniae after recurrent infections in an immunocompromised host. Diagn Microbiol Infect Dis. 2014;80:87\u20139.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"300_CR103","first-page":"86","volume":"12","author":"AL Barsuk","year":"2020","unstructured":"Barsuk AL, Nekaeva ES, Lovtsova LV, Urakov AL. Selective intestinal decontamination as a method for preventing infectious complications (Review). Mod Technol Med. 2020;12:86\u201395.","journal-title":"Mod Technol Med."},{"key":"300_CR104","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1093\/jac\/dku092","volume":"69","author":"E Buelow","year":"2014","unstructured":"Buelow E, Gonzalez TB, Versluis D, Oostdijk EAN, Ogilvie LA, van Mourik MSM, et al. Effects of selective digestive decontamination (SDD) on the gut resistome. J Antimicrob Chemother. 2014;69:2215\u201323.","journal-title":"J Antimicrob Chemother"},{"key":"300_CR105","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1155\/2009\/290130","volume":"20","author":"KB Laupland","year":"2009","unstructured":"Laupland KB, Fisman DN. Selective digestive tract decontamination: a tough pill to swallow. Can J Infect Dis Med Microbiol. 2009;20:9\u201311.","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"300_CR106","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/tid.12550","volume":"18","author":"BJ Webb","year":"2016","unstructured":"Webb BJ, Brunner A, Ford CD, Gazdik MA, Petersen FB, Hoda D. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients. Transpl Infect Dis Off J Transplant Soc. 2016;18:628\u201333.","journal-title":"Transpl Infect Dis Off J Transplant Soc"},{"key":"300_CR107","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/nrc.2018.10","volume":"18","author":"Y Shono","year":"2018","unstructured":"Shono Y, van den Brink MRM. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation. Nat Rev Cancer. 2018;18:283\u201395.","journal-title":"Nat Rev Cancer"},{"key":"300_CR108","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1172\/JCI125797","volume":"129","author":"DN Fredricks","year":"2019","unstructured":"Fredricks DN. The gut microbiota and graft-versus-host disease. J Clin Invest. 2019;129:1808\u201317.","journal-title":"J Clin Invest"},{"key":"300_CR109","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMra1609337","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser R, Blazar BR. Acute graft-versus-host disease - biologic process, prevention, and therapy. N Engl J Med. 2017;377:2167\u201379.","journal-title":"N Engl J Med"},{"key":"300_CR110","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.644982","volume":"12","author":"T Hong","year":"2021","unstructured":"Hong T, Wang R, Wang X, Yang S, Wang W, Gao Q, et al. Interplay between the intestinal microbiota and acute graft-versus-host disease: experimental evidence and clinical significance. Front Immunol. 2021;12: 644982.","journal-title":"Front Immunol"},{"key":"300_CR111","first-page":"2124627","volume":"2022","author":"J Li","year":"2022","unstructured":"Li J, Zhang X, Chen Y, Zheng Q, Zhao M, Jiang H. A promising insight: the potential influence and therapeutic value of the gut microbiota in GI GVHD. Oxid Med Cell Longev. 2022;2022:2124627.","journal-title":"Oxid Med Cell Longev."},{"key":"300_CR112","doi-asserted-by":"publisher","first-page":"4920","DOI":"10.1158\/1078-0432.CCR-23-2369","volume":"29","author":"A Rashidi","year":"2023","unstructured":"Rashidi A, Ebadi M, Rehman TU, Elhusseini H, Kazadi D, Halaweish H, et al. Potential of fecal microbiota transplantation to prevent acute graft-versus-host disease: analysis from a phase 2 trial. Clin Cancer Res Off J Am Assoc Cancer Res. 2023;29:4920\u20139.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"300_CR113","doi-asserted-by":"publisher","first-page":"e136841","DOI":"10.1172\/jci.insight.136841","volume":"6","author":"MH Sofi","year":"2021","unstructured":"Sofi MH, Wu Y, Ticer T, Schutt S, Bastian D, Choi H-J, et al. A single strain of Bacteroides fragilis protects gut integrity and reduces GVHD. JCI Insight. 2021;6:e136841.","journal-title":"JCI Insight"},{"key":"300_CR114","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1182\/blood-2014-02-554725","volume":"124","author":"Y Taur","year":"2014","unstructured":"Taur Y, Jenq RR, Perales M-A, Littmann ER, Morjaria S, Ling L, et al. The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014;124:1174\u201382.","journal-title":"Blood"},{"key":"300_CR115","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3390\/biology11050785","volume":"11","author":"S Ugrayov\u00e1","year":"2022","unstructured":"Ugrayov\u00e1 S, \u0160vec P, Hric I, \u0160ardz\u00edkov\u00e1 S, Kub\u00e1\u0148ov\u00e1 L, Penesov\u00e1 A, et al. Gut microbiome suffers from hematopoietic stem cell transplantation in childhood and its characteristics are positively associated with intra-hospital physical exercise. Biology. 2022;11:785.","journal-title":"Biology"},{"key":"300_CR116","doi-asserted-by":"publisher","first-page":"1058272","DOI":"10.3389\/fimmu.2022.1058272","volume":"13","author":"L Zhang","year":"2022","unstructured":"Zhang L, Xiang Y, Li Y, Zhang J. Gut microbiome in multiple myeloma: mechanisms of progression and clinical applications. Front Immunol. 2022;13:1058272.","journal-title":"Front Immunol"},{"key":"300_CR117","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/bjh.16205","volume":"188","author":"S Kusakabe","year":"2020","unstructured":"Kusakabe S, Fukushima K, Maeda T, Motooka D, Nakamura S, Fujita J, et al. Pre- and post-serial metagenomic analysis of gut microbiota as a prognostic factor in patients undergoing haematopoietic stem cell transplantation. Br J Haematol. 2020;188:438\u201349.","journal-title":"Br J Haematol"},{"key":"300_CR118","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/10428194.2022.2131410","volume":"64","author":"C D\u2019Angelo","year":"2023","unstructured":"D\u2019Angelo C, Sudakaran S, Asimakopoulos F, Hematti P, El-Gamal D, Safdar N, et al. Perturbation of the gut microbiome and association with outcomes following autologous stem cell transplantation in patients with multiple myeloma. Leuk Lymphoma. 2023;64:87\u201397.","journal-title":"Leuk Lymphoma"},{"key":"300_CR119","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1182\/blood.2020006923","volume":"137","author":"N Khan","year":"2021","unstructured":"Khan N, Lindner S, Gomes ALC, Devlin SM, Shah GL, Sung AD, et al. Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study. Blood. 2021;137:1527\u201337.","journal-title":"Blood"},{"key":"300_CR120","first-page":"94","volume":"40","author":"G Ren","year":"2021","unstructured":"Ren G, Zhang J, Li M, Tang Z, Yang Z, Cheng G, et al. Gut microbiota composition influences outcomes of skeletal muscle nutritional intervention via blended protein supplementation in posttransplant patients with hematological malignancies. Clin Nutr Edinb Scotl. 2021;40:94\u2013102.","journal-title":"Clin Nutr Edinb Scotl"},{"key":"300_CR121","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1038\/s41467-022-32960-3","volume":"13","author":"Y Hu","year":"2022","unstructured":"Hu Y, Li J, Ni F, Yang Z, Gui X, Bao Z, et al. CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies. Nat Commun. 2022;13:5313.","journal-title":"Nat Commun"},{"key":"300_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112582","volume":"203","author":"T Xia","year":"2020","unstructured":"Xia T, Zhang B, Li Y, Fang B, Zhu X, Xu B, et al. New insight into 20(S)-ginsenoside Rh2 against T-cell acute lymphoblastic leukemia associated with the gut microbiota and the immune system. Eur J Med Chem. 2020;203: 112582.","journal-title":"Eur J Med Chem"},{"key":"300_CR123","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fonc.2018.00086","volume":"8","author":"JA Seidel","year":"2018","unstructured":"Seidel JA, Otsuka A, Kabashima K. Anti-PD-1 and Anti-CTLA-4 therapies in cancer: mechanisms of action, efficacy, and limitations. Front Oncol. 2018;8:86.","journal-title":"Front Oncol"},{"key":"300_CR124","doi-asserted-by":"publisher","first-page":"eaan5931","DOI":"10.1126\/science.aan5931","volume":"360","author":"C Ma","year":"2018","unstructured":"Ma C, Han M, Heinrich B, Fu Q, Zhang Q, Sandhu M, et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science. 2018;360:eaan5931.","journal-title":"Science"},{"key":"300_CR125","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.gtc.2016.09.012","volume":"46","author":"SM Vindigni","year":"2017","unstructured":"Vindigni SM, Surawicz CM. Fecal microbiota transplantation. Gastroenterol Clin North Am. 2017;46:171\u201385.","journal-title":"Gastroenterol Clin North Am"},{"issue":"Suppl 1","key":"300_CR126","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1016\/j.jfma.2018.08.011","volume":"118","author":"J-W Wang","year":"2019","unstructured":"Wang J-W, Kuo C-H, Kuo F-C, Wang Y-K, Hsu W-H, Yu F-J, et al. Fecal microbiota transplantation: review and update. J Formos Med Assoc Taiwan Yi Zhi. 2019;118(Suppl 1):S23-31.","journal-title":"J Formos Med Assoc Taiwan Yi Zhi"},{"key":"300_CR127","first-page":"84","volume":"58","author":"S Tkach","year":"2022","unstructured":"Tkach S, Dorofeyev A, Kuzenko I, Boyko N, Falalyeyeva T, Boccuto L, et al. Current status and future therapeutic options for fecal microbiota transplantation. Med Kaunas Lith. 2022;58:84.","journal-title":"Med Kaunas Lith"},{"key":"300_CR128","doi-asserted-by":"publisher","first-page":"eaaz8926","DOI":"10.1126\/scitranslmed.aaz8926","volume":"12","author":"YF van Lier","year":"2020","unstructured":"van Lier YF, Davids M, Haverkate NJE, de Groot PF, Donker ML, Meijer E, et al. Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients. Sci Transl Med. 2020;12:eaaz8926.","journal-title":"Sci Transl Med"},{"key":"300_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.678476","volume":"12","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Li X, Zhou Y, Gao J, Jiao Y, Zhu B, et al. Safety and efficacy of fecal microbiota transplantation for grade IV steroid refractory GI-GvHD patients: interim results from FMT2017002 trial. Front Immunol. 2021;12: 678476.","journal-title":"Front Immunol"},{"key":"300_CR130","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.cell.2018.08.047","volume":"174","author":"J Suez","year":"2018","unstructured":"Suez J, Zmora N, Zilberman-Schapira G, Mor U, Dori-Bachash M, Bashiardes S, et al. Post-antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell. 2018;174:1406-1423.e16.","journal-title":"Cell"},{"key":"300_CR131","first-page":"853","volume":"40","author":"Q Wang","year":"2019","unstructured":"Wang Q, Fu YW, Wang YQ, Ai H, Yuan FF, Wei XD, et al. Fecal microbiota transplantation for patients with refractory diarrhea after allogeneic hematopoietic stem cell transplantation. Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi. 2019;40:853\u20135.","journal-title":"Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi"},{"key":"300_CR132","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1038\/s41467-021-23376-6","volume":"12","author":"F Malard","year":"2021","unstructured":"Malard F, Vekhoff A, Lapusan S, Isnard F, Dincan-Corda E, Rey J, et al. Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients. Nat Commun. 2021;12:3084.","journal-title":"Nat Commun"},{"key":"300_CR133","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1182\/bloodadvances.2018017731","volume":"2","author":"Z DeFilipp","year":"2018","unstructured":"DeFilipp Z, Peled JU, Li S, Mahabamunuge J, Dagher Z, Slingerland AE, et al. Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity. Blood Adv. 2018;2:745\u201353.","journal-title":"Blood Adv"},{"key":"300_CR134","doi-asserted-by":"publisher","first-page":"p9489","DOI":"10.1126\/scitranslmed.aap9489","volume":"10","author":"Y Taur","year":"2018","unstructured":"Taur Y, Coyte K, Schluter J, Robilotti E, Figueroa C, Gjonbalaj M, et al. Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant. Sci Transl Med. 2018;10:p9489.","journal-title":"Sci Transl Med"},{"key":"300_CR135","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12934-021-01589-0","volume":"20","author":"X-Y Kuai","year":"2021","unstructured":"Kuai X-Y, Yao X-H, Xu L-J, Zhou Y-Q, Zhang L-P, Liu Y, et al. Evaluation of fecal microbiota transplantation in Parkinson\u2019s disease patients with constipation. Microb Cell Factories. 2021;20:98.","journal-title":"Microb Cell Factories"},{"key":"300_CR136","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/MPH.0000000000001497","volume":"41","author":"J Reyna-Figueroa","year":"2019","unstructured":"Reyna-Figueroa J, Barr\u00f3n-Calvillo E, Garc\u00eda-Parra C, Galindo-Delgado P, Contreras-Ochoa C, Lagunas-Mart\u00ednez A, et al. Probiotic supplementation decreases chemotherapy-induced gastrointestinal side effects in patients with acute leukemia. J Pediatr Hematol Oncol. 2019;41:468\u201372.","journal-title":"J Pediatr Hematol Oncol"},{"key":"300_CR137","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1093\/annonc\/mdu106","volume":"25","author":"MG Redman","year":"2014","unstructured":"Redman MG, Ward EJ, Phillips RS. The efficacy and safety of probiotics in people with cancer: a systematic review. Ann Oncol. 2014;25:1919\u201329.","journal-title":"Ann Oncol"},{"key":"300_CR138","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SPC.0000000000000338","volume":"12","author":"HR Wardill","year":"2018","unstructured":"Wardill HR, Van Sebille YZA, Ciorba MA, Bowen JM. Prophylactic probiotics for cancer therapy-induced diarrhoea: a meta-analysis. Curr Opin Support Palliat Care. 2018;12:187\u201397.","journal-title":"Curr Opin Support Palliat Care"},{"key":"300_CR139","doi-asserted-by":"publisher","first-page":"3014","DOI":"10.3390\/nu14153014","volume":"14","author":"X Wu","year":"2022","unstructured":"Wu X, Hou Q, Zhao Z, Wang J, Guo Y, Lu L, et al. Effects of soy-whey protein nutritional supplementation on hematopoiesis and immune reconstitution in an allogeneic transplanted mice. Nutrients. 2022;14:3014.","journal-title":"Nutrients"},{"key":"300_CR140","doi-asserted-by":"publisher","first-page":"665901","DOI":"10.3389\/fimmu.2021.665901","volume":"12","author":"R Zhou","year":"2021","unstructured":"Zhou R, He D, Xie J, Zhou Q, Zeng H, Li H, et al. The synergistic effects of polysaccharides and ginsenosides from American Ginseng (Panax quinquefolius L.) ameliorating cyclophosphamide-induced intestinal immune disorders and gut barrier dysfunctions based on microbiome-metabolomics analysis. Front Immunol. 2021;12:665901.","journal-title":"Front Immunol"},{"key":"300_CR141","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre M-L, et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science. 2018;359:104\u20138.","journal-title":"Science"},{"key":"300_CR142","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1186\/s12864-016-2965-y","volume":"17","author":"SV Rajagopala","year":"2016","unstructured":"Rajagopala SV, Yooseph S, Harkins DM, Moncera KJ, Zabokrtsky KB, Torralba MG, et al. Gastrointestinal microbial populations can distinguish pediatric and adolescent acute lymphoblastic leukemia (ALL) at the time of disease diagnosis. BMC Genom. 2016;17:635.","journal-title":"BMC Genom"},{"key":"300_CR143","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1007\/s00248-019-01448-x","volume":"79","author":"SV Rajagopala","year":"2020","unstructured":"Rajagopala SV, Singh H, Yu Y, Zabokrtsky KB, Torralba MG, Moncera KJ, et al. Persistent gut microbial dysbiosis in children with acute lymphoblastic leukemia (ALL) during chemotherapy. Microb Ecol. 2020;79:1034\u201343.","journal-title":"Microb Ecol"},{"key":"300_CR144","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12887-020-02192-9","volume":"20","author":"X Gao","year":"2020","unstructured":"Gao X, Miao R, Zhu Y, Lin C, Yang X, Jia R, et al. A new insight into acute lymphoblastic leukemia in children: influences of changed intestinal microfloras. BMC Pediatr. 2020;20:290.","journal-title":"BMC Pediatr"},{"key":"300_CR145","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12885-020-6654-5","volume":"20","author":"LL Chua","year":"2020","unstructured":"Chua LL, Rajasuriar R, Lim YAL, Woo YL, Loke P, Ariffin H. Temporal changes in gut microbiota profile in children with acute lymphoblastic leukemia prior to commencement-, during-, and post-cessation of chemotherapy. BMC Cancer. 2020;20:151.","journal-title":"BMC Cancer"},{"key":"300_CR146","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.558799","volume":"10","author":"X Liu","year":"2020","unstructured":"Liu X, Zou Y, Ruan M, Chang L, Chen X, Wang S, et al. Pediatric acute lymphoblastic leukemia patients exhibit distinctive alterations in the gut microbiota. Front Cell Infect Microbiol. 2020;10: 558799.","journal-title":"Front Cell Infect Microbiol"},{"key":"300_CR147","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29308","volume":"68","author":"R Bhuta","year":"2021","unstructured":"Bhuta R, DeNardo B, Wang J, Atoyan J, Zhang Y, Nelson D, et al. Durable changes in the gut microbiome in survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer. 2021;68: e29308.","journal-title":"Pediatr Blood Cancer"}],"container-title":["Oncology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40487-024-00300-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40487-024-00300-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40487-024-00300-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T15:03:50Z","timestamp":1732115030000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40487-024-00300-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,1]]},"references-count":147,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["300"],"URL":"https:\/\/doi.org\/10.1007\/s40487-024-00300-8","relation":{},"ISSN":["2366-1070","2366-1089"],"issn-type":[{"value":"2366-1070","type":"print"},{"value":"2366-1089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,1]]},"assertion":[{"value":"25 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Qiang Yang, Zexin Wang, Miao Liu, and Lingling Gan declare that they have no competing interests. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}